Skip to news
JQJO
Latest

Covid shots may boost cancer immunotherapy survival | JQJO

Covid shots may boost cancer immunotherapy survival

Covid shots may boost cancer immunotherapy survival

Tap title to read story

0:00 / 0:43

Scientists reported at the ESMO meeting in Berlin that cancer patients who received an mRNA Covid vaccine within 100 days before starting immunotherapy lived longer in retrospective analyses. Among more than 1,000 people with advanced non-small cell lung cancer, median survival was about three years for the vaccinated versus just over 1.5 years for others; similar advantages appeared in metastatic melanoma. Mouse experiments suggest the shots activate dendritic cells that help T cells target tumors. Researchers plan a Phase 3 trial, while outside experts urge caution about early, retrospective findings.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

SpaceX Secures Texas Air Permit

Tap title to read story

0:00 / 0:00

Ryan Fox Seeks Birthday Victory

Tap title to read story

0:00 / 0:35

JQJO

Find your next story

Search JQJO’s current coverage.